GovWire

Guidance: Innovation Accelerator

Medicines Healthcare Products Regulatory Agency

July 15
10:53 2022

Details

The Innovation Accelerator service will help provide innovators access to MHRA scientific expertise and regulatory guidance, helping developers of innovative products (medicines, medical devices (including software) and blood components for transfusion) connect more dynamically with an enhanced advice and signposting service.

The Innovation Accelerator functions bring together the Innovation Office, the Regulatory Advice Service for Regenerative Medicines (RASRM), Regulatory Science and horizon scanning. It also supports the delivery of the Innovative Licensing and Access Pathway (ILAP).

Published 15 July 2022

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: